Full Press Release Details
PHILADELPHIA, Oct. 5, 2020 /PRNewswire/ -- CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two virtual investor conferences in October 2020.
Chardan 4th Annual Genetic Medicines Conference
Tuesday, October 6, 2020 at 11:00 am EST
7th Solebury Trout Private Company Showcase Co-Hosted by BMO and Davis Polk
Thursday, October 15, 2020 at 10:40 am EST
About CARISMA Therapeutics Inc.
CARISMA Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.
For more information, please visit www.carismatx.com
Christina Khoury-Folkens
SOURCE CARISMA Therapeutics Inc.
21 %
more press release views with